Guggenhime Andrew
Vaxcyte, Inc. · PRESIDENT AND CFO
Guggenhime Andrew is listed in filings as PRESIDENT AND CFO at Vaxcyte, Inc.. This profile follows SEC Form 4 activity through Mar 11, 2026, including sale activity. Recent filings connect the profile to Vaxcyte, Inc. (PCVX) and Caribou Biosciences, Inc. (CRBU). The current snapshot covers public activity from Oct 22, 2024 to Mar 11, 2026. Reported amounts are shown as $60.6K to $55.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $517k6.2k shares | SellFeb 18, 2025 | $83.64 | $56.74 | |
| $154k1.8k shares | SellFeb 18, 2025 | $84.58 | $56.74 |